PHAST: Physical Activity in Substitution Therapy (PHAST)

December 10, 2015 updated by: University Hospital, Basel, Switzerland

PHAST: Influence of Exercise Training on Substance Use, Substance Craving, Quality of Life, Mental Health, Sleep, and Physical Health in Patients Suffering From Opiate Dependence While Under Substitution Therapy

The aim is to examine the effect of exercise (EX) training on individuals currently receiving ST - either opiate replacement therapy (ORT) or heroin-assisted treatment (HAT) - for their opiate dependence. Main outcome variables will be: cardiovascular fitness; consumption of substances (e.g. "street heroin", cocaine, cannabis, alcohol, cigarettes) other than prescribed ST or other prescribed medications; substance craving; blood pressure; lung function; resting pulse; social interaction; self-control capacity; objective and subjective sleep; cortisol levels; quality adjusted life years (QALYs); depression; mood. Covariates are current substitution dose and psychiatric diagnoses.

Study Overview

Status

Completed

Detailed Description

The investigators aim is to carry out a randomized controlled trial comparing exercise training group and a control group of patients receiving substitution therapy (ST). The specific goals of the study are:

  1. To understand the exercise preferences, barriers to participation, motivation, experiences and attitudes regarding exercise training in patients under ST.
  2. To examine whether a 12-week exercise programme affects the mental health, subjective and objective sleep, quality of life, self-control capacity, substance craving, hair cortisol levels, secondary consumption, cardiovascular fitness, blood pressure, lung function, resting pulse, and social interaction in patients receiving ST.
  3. To compare the effects of the EX and control conditions on the above-mentioned outcome variables.
  4. To examine to what degree the covariates of heroin substitution dose and psychiatric comorbidities affect outcome variables.
  5. To explore to what extent objective variables (cardiovascular fitness, pulse, blood pressure, lung function, cortisol, objective sleep-EEG-parameters) and subjective-psychological dimensions (subjective sleep, social interaction, symptoms of depression and anxiety, self-control, substance craving) are interrelated.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4052
        • Department for Sport, Exercise and Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patient at the Ambulanter Dienst Sucht or Janus clinics in Basel Town (BS); currently under substitution therapy

Exclusion Criteria:

Declared unfit to participate by clinic personnel due to physical disability or severe psychological disturbance or cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Sport Group
Participants randomised to the exercise condition will receive 12 weeks of physical exercise training. Once they have been assigned to this group, they will be informed about the training programme and its content. Training will be carried out in groups (two groups of ten or four groups of five, depending on scheduling, sport preferences, available materials) to ensure that individual attention can be paid to each participant.
Other: Control Group
The control group will not receive any exercise training. In order to control, as far as possible, for the potentially therapeutic effects of extra contact time with investigators, and the potentially motivational elements of participation in an intervention, the C group will have equal contact time with an investigator and participate in a leisure program without physical activity component. This time will be filled with group mealtimes, games, films, painting, handcrafts, stretching or relaxation exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Craving measured by the Brief Substance Craving Scale (translated)
Time Frame: 6 months
Craving will be measured by the Brief Substance Craving Scale (translated)
6 months
Secondary substance consumption assessed using the Time Line Follow Back method
Time Frame: 6 months
This will be assessed using the Time Line Follow Back method
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression assessed using the Allgemeine Depressionskala ( Depression Scale)
Time Frame: 6 months
Depression will be assessed using the Allgemeine Depressionskala ( Depression Scale)
6 months
Self control measured using the Short Self Control Scale (translated)
Time Frame: 6 months
This will be measured using the Short Self Control Scale (translated)
6 months
Subjective sleep measured using the Insomnia Severity Index (translated)
Time Frame: 6 months
This will be measured using the Insomnia Severity Index (translated)
6 months
Physical activity level measured using the International Physical Activity Questionnaire
Time Frame: 6 months
This will be measured using the International Physical Activity Questionnaire
6 months
Perceived Stress measured using the Perceived Stress Scale (translated)
Time Frame: 6 months
Will be measured using the Perceived Stress Scale (translated)
6 months
Quality adjusted life years assessed using the Short Form (SF)36 questionnaire
Time Frame: 6 months
This will be assessed using the Short Form (SF)36 questionnaire
6 months
Blood pressure measured using a digital sphygmomanometer
Time Frame: 6 months
This will be measured using a digital sphygmomanometer
6 months
Lung function measured with a Spirobank Spirometer
Time Frame: 6 months
Lung function will be measured with a Spirobank Spirometer
6 months
Hand grip strength assessed using a Hydraulic Hand Dynamometer.
Time Frame: 6 months
This will be assessed using a Hydraulic Hand Dynamometer.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Flora Colledge, PhD, Department for Sport, Exercise and Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

November 1, 2015

Study Completion (Actual)

November 1, 2015

Study Registration Dates

First Submitted

November 27, 2014

First Submitted That Met QC Criteria

December 4, 2014

First Posted (Estimate)

December 5, 2014

Study Record Updates

Last Update Posted (Estimate)

December 11, 2015

Last Update Submitted That Met QC Criteria

December 10, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • UHospitalSwitz

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance-related Disorders

Clinical Trials on Sport

3
Subscribe